MedPath

Mindfulness-Based Childbirth Education for Pregnant Women With Distress

Not Applicable
Completed
Conditions
PRENATAL DISTRESS
Registration Number
NCT07122115
Lead Sponsor
Kayseri Training and Research Hospital
Brief Summary

This randomized controlled trial aimed to evaluate the effects of a mindfulness-based childbirth and parenting education program on pregnant women experiencing prenatal distress. A total of 31 participants were randomly assigned to either an intervention group, which received an 8-week mindfulness-based education, or a control group, which received standard prenatal care. The study assessed outcomes such as pregnancy-related stress, fear of childbirth, conscious awareness, maternal attachment, and postpartum adaptation.

Detailed Description

This study was conducted to investigate the effects of a mindfulness-based childbirth and parenting education program on pregnant women who were identified as having prenatal distress. A randomized controlled trial design was used with a pre-test/post-test model. The participants were recruited from Kayseri City Training and Research Hospital's Pregnancy School and Outpatient Clinic between November and December 2022.

A total of 201 pregnant women were screened using the Tilburg Pregnancy Distress Scale (TPDS), and 31 women who scored 28 or higher and met the inclusion criteria were selected. Participants were randomly assigned into two groups: an intervention group (n=16) that received an 8-week mindfulness-based childbirth and parenting education program, and a control group (n=15) that received standard prenatal education.

The mindfulness-based program was conducted online and included guided mindfulness practices, psychoeducation, breathing exercises, and home assignments. Each session lasted approximately 120 minutes and was held once a week for eight consecutive weeks. Participants were also encouraged to practice formal and informal mindfulness exercises at home throughout the program.

The data were collected using several validated instruments, including the Tilburg Pregnancy Distress Scale, Mindful Attention Awareness Scale (MAAS), Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ), Visual Analog Scale (VAS) for labor pain, Maternal Attachment Scale, and Postpartum Self-Evaluation Questionnaire. Data collection occurred at multiple time points: before the intervention, after the intervention, on the first postpartum day, and during the first and fourth postpartum months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
31
Inclusion Criteria

Female participants aged 18 to 35

First-time pregnancy (primigravida)

Gestational age between 24 and 32 weeks

No chronic medical or psychiatric conditions

Able to participate in online sessions

TPDS (Tilburg Pregnancy Distress Scale) score of 28 or higher

Minimum literacy level to understand consent and questionnaires

Voluntary participation and signed informed consent

Exclusion Criteria
  • High-risk pregnancy (e.g., preeclampsia, placenta previa)

Multiple pregnancy (e.g., twins or more)

Existing diagnosis of major psychiatric disorders

Participation in any previous mindfulness training

Inability to complete follow-up assessments

Non-consent or withdrawal from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Prenatal Distress LevelFrom baseline (pre-intervention) to immediately post-intervention (approximately 8 weeks)

Measured using the Tilburg Pregnancy Distress Scale (TPDS), which assesses pregnancy-related emotional distress.

Secondary Outcome Measures
NameTimeMethod
Change in Mindful AwarenessBaseline and post-intervention (8 weeks)

Measured using the Mindful Attention Awareness Scale (MAAS). Higher scores indicate greater mindfulness.

Trial Locations

Locations (1)

Kayseri City Training and Research Hospital

🇹🇷

Kayseri̇, Kocasi̇nan, Turkey

Kayseri City Training and Research Hospital
🇹🇷Kayseri̇, Kocasi̇nan, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.